Costs of cancer care in children and adolescents in Ontario, Canada

Pediatric Blood & Cancer
Claire de OliveiraMurray Krahn

Abstract

Cancer in children and adolescents presents unique issues regarding treatment and survivorship, but few studies have measured economic burden. We estimated health care costs by phase of cancer care, from the public payer perspective, in population-based cohorts. Children newly diagnosed at ages 0 days-14.9 years and adolescents newly diagnosed at 15-19.9 years, from January 1, 1995 to June 30, 2010, were identified from Ontario cancer registries, and each matched to three noncancer controls. Data were linked with administrative records describing resource use for cancer and other health care. Total and net (patients minus controls) resource-specific costs ($CAD2012) were estimated using generalized estimating equations for four phases of care: prediagnosis (60 days), initial (360 days), continuing (variable), final (360 days). Mean ages at diagnosis were 6 years for children (N = 4,606) and 17 years for adolescents (N = 2,443). Mean net prediagnosis phase 60-day costs were $6,177 for children and $1,018 for adolescents. Costs for initial, continuing, and final phases were $138,161, $15,756, and $316,303 per 360 days for children, and $62,919, $7,071, and $242,008 for adolescents. The highest initial phase costs were for leukemi...Continue Reading

References

Aug 15, 1983·Cancer·S B LanskyN U Cairns
Mar 15, 1995·Journal of the National Cancer Institute·M L Brown, B Fireman
Feb 15, 2001·Medical Care·R J ReidM Atkinson
Aug 21, 2002·Medical Care·Martin L BrownRuth Etzioni
Feb 13, 2003·American Journal of Epidemiology·James A HanleyJanet E Forrester
Apr 3, 2003·International Journal of Cancer. Journal International Du Cancer·Mark L GreenbergCorin Greenberg
Feb 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Klein-GeltinkM L Greenberg
Feb 16, 2005·Cancer·Eva Steliarova-FoucherPeter Kaatsch
Jun 16, 2005·Journal of Pediatric Hematology/oncology·Marc B RosenmanPhilip P Breitfeld
Oct 13, 2005·Statistics in Medicine·Peter C Austin, Muhammad M Mamdani
Dec 20, 2005·Journal of Clinical Epidemiology·Stephen HallEric Holowaty
May 1, 2008·Journal of the National Cancer Institute·K Robin YabroffMartin L Brown
Jun 12, 2008·Journal of the National Cancer Institute·Joan L WarrenMartin L Brown
Jun 16, 2009·Pediatric Blood & Cancer·Yin LiuCi Pan
Mar 8, 2012·International Journal of Cancer. Journal International Du Cancer·William FurlongRonald D Barr
Dec 26, 2012·Pediatrics·Heidi V RussellJ Michael Swint
Feb 4, 2014·CA: a Cancer Journal for Clinicians·Elizabeth WardAhmedin Jemal
Mar 4, 2014·The Journal of Rheumatology·Laurel BrotenSasha Bernatsky
Jun 25, 2015·Journal of Oncology Practice·Sapna KaulRichard E Nelson
Oct 21, 2016·BMC Cancer·Claire de OliveiraMurray D Krahn
Mar 16, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Claire de OliveiraMurray D Krahn

❮ Previous
Next ❯

Citations

Jan 5, 2019·Journal of Magnetic Resonance Imaging : JMRI·Nishard AbdeenNazih Shenouda
Apr 25, 2020·International Journal of Environmental Research and Public Health·Katharina M D MerolliniMichael G Kimlin
Jul 3, 2021·International Journal of Environmental Research and Public Health·Florencia Borrescio-Higa, Nieves Valdés
Aug 7, 2021·Journal of the National Comprehensive Cancer Network : JNCCN·Owen TanRupendra Shrestha

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved